Stephanie Reuter
![](/-/media/country/corp/contact/press-contact/stephanie-reuter.jpg?h=416&iar=0&mw=324&w=324&rev=82a661d2f5da4130b81ef23a9902cea3&sc_lang=en&hash=027869D9162875A25927B362C6EDE224)
stephanie.reuter@hartmann.info
+49 173 3453885
Sales and organic sales growth | |
Group | EUR 593.3 million (+2.0%) |
Wound Management | EUR 111.4 million (-1.3%) |
Infection Management | EUR 203.4 million (+23.9%) |
Incontinence Management | EUR 168.6 million (-9.5%) |
Other Group Activities | EUR 109.9 million (-6.7%) |
"As expected, the year 2021 has gotten off to a challenging start. The coronavirus pandemic is having a significant negative impact on our performance in some business areas. For us, it therefore remains crucial to implement our Transformation Program consistently and successfully."
The HARTMANN GROUP is one of the leading European providers of professional medical and care products and associated services. Every day, healthcare professionals and patients rely on HARTMANN brands in the segments of Incontinence Management (e.g. MoliCare®), Wound Care (e.g. Zetuvit®, Cosmopor®) and Infection Management (e. g. Sterillium®). This is expressed in our brand promise of “Helps. Cares. Protects.” HARTMANN generated sales of EUR 2.3 billion in the 2023 financial year. Founded in 1818, the Company sells its products and solutions in 130 countries around the world. For the future, the HARTMANN GROUP is currently implementing its strategic Transformation Program with its high-performance, customer-oriented and passionate team.
To learn more about the HARTMANN GROUP, visit www.corporate.hartmann.info.